A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA.
COVID-19
MqSOFA
NEWS2
SARS-CoV-2
in-hospital mortality
nCOV19
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
12 Apr 2022
12 Apr 2022
Historique:
received:
18
03
2022
revised:
12
04
2022
accepted:
12
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Background: Since 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a rapidly spreading pandemic. The present study aims to compare a modified quick SOFA (MqSOFA) score with the NEWS-2 score to predict in-hospital mortality (IHM), 30-days mortality and recovery setting. Methods: All patients admitted from March to October 2020 to the Emergency Department of St. Anna Hospital, Ferrara, Italy with clinically suspected SARS-CoV-2 infection were retrospectively included in this single-centre study and evaluated with the MqSOFA and NEWS-2 scores. Statistical and logistic regression analyses were applied to our database. Results: A total of 3359 individual records were retrieved. Among them, 2716 patients were excluded because of a negative nasopharyngeal swab and 206 for lacking data; thus, 437 patients were eligible. The data showed that the MqSOFA and NEWS-2 scores equally predicted IHM (p < 0.001) and 30-days mortality (p < 0.001). Higher incidences of coronary artery disease, congestive heart failure, cerebrovascular accidents, dementia, chronic kidney disease and cancer were found in the deceased vs. survived group. Conclusions: In this study we confirmed that the MqSOFA score was non-inferior to the NEWS-2 score in predicting IHM and 30-days mortality. Furthermore, the MqSOFA score was easier to use than NEWS-2 and is more suitable for emergency settings. Neither the NEWS-2 nor the MqSOFA scores were able to predict the recovery setting.
Identifiants
pubmed: 35456856
pii: microorganisms10040806
doi: 10.3390/microorganisms10040806
pmc: PMC9032690
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Korean Med Sci. 2020 Jun 29;35(25):e234
pubmed: 32597046
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734
pubmed: 34914670
Infection. 2022 Feb 18;:
pubmed: 35179719
JAMA. 2020 Sep 8;324(10):998-1000
pubmed: 32789492
Int J Infect Dis. 2022 Mar;116:38-42
pubmed: 34971823
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32817205
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):825-831
pubmed: 33118057
Eur Respir Rev. 2020 Nov 5;29(158):
pubmed: 33153991
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264
pubmed: 32235085
Front Immunol. 2020 Nov 30;11:598404
pubmed: 33329592
Am J Emerg Med. 2020 Oct;38(10):2074-2080
pubmed: 33142178
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Viruses. 2021 Aug 25;13(9):
pubmed: 34578269
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109
pubmed: 33161221
J Community Health. 2020 Dec;45(6):1270-1282
pubmed: 32918645
Crit Care Med. 2021 Mar 1;49(3):e219-e234
pubmed: 33555780
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520947505
pubmed: 32812440
Eur J Heart Fail. 2020 Dec;22(12):2205-2215
pubmed: 32833283
Oncologist. 2021 Jan;26(1):
pubmed: 32845538
Eur Respir J. 2020 Sep 10;56(3):
pubmed: 32675205
BMC Med. 2021 Jan 21;19(1):23
pubmed: 33472631
Respir Med. 2013 Jun;107(6):789-99
pubmed: 23490227
Scand J Trauma Resusc Emerg Med. 2020 Jul 13;28(1):66
pubmed: 32660623
Biomedicines. 2021 Aug 18;9(8):
pubmed: 34440240
Resuscitation. 2020 Nov;156:84-91
pubmed: 32918985
Am J Kidney Dis. 2021 Feb;77(2):190-203.e1
pubmed: 32961244
Eur Heart J. 2020 May 14;41(19):1821-1829
pubmed: 32383763
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264